Literature DB >> 20675515

Incomparable effectiveness--apples to apples?

F David Winter, Kevin R Wheelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675515      PMCID: PMC2912740          DOI: 10.4065/mcp.2010.0009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Authors:  Zheng Zhou; Elham Rahme; Michal Abrahamowicz; Jack V Tu; Mark J Eisenberg; Karin Humphries; Peter C Austin; Louise Pilote
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

2.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

3.  High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Authors:  Terje R Pedersen; Ole Faergeman; John J P Kastelein; Anders G Olsson; Matti J Tikkanen; Ingar Holme; Mogens Lytken Larsen; Fredrik S Bendiksen; Christina Lindahl; Michael Szarek; John Tsai
Journal:  JAMA       Date:  2005-11-16       Impact factor: 56.272

4.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Authors:  P Jones; S Kafonek; I Laurora; D Hunninghake
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

5.  Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population.

Authors:  Ross J Simpson; James Signorovitch; Howard Birnbaum; Jasmina Ivanova; Cristina Connolly; Yohanne Kidolezi; Andreas Kuznik
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.